Journal List > J Bacteriol Virol > v.37(2) > 1033889

TOOLS
Jung: Antimicrobial Activity of Extract and Fractions from Drynaria fortunei Against Oral Bacteria
Original Article

J Bacteriol Virol 2007;37(2):61-68.

Published online: 18 February 2007

DOI: https://doi.org/10.4167/jbv.2007.37.2.61

Antimicrobial Activity of Extract and Fractions from Drynaria fortunei Against Oral Bacteria

Eun-Kyung Jung∗

Department of Dental Hygiene, Ulsan College, San 160-1 Hwajeong-Dong, Dong-Gu, Ulsan, 682-715, Korea

∗Corresponding author: Prof. Eun-Kyung Jung. Department of Dental Hygiene, Ulsan College, San 160-1 Hwajeong-Dong, Dong-Gu, Ulsan, 682-715, Korea. Phone: +82-52-230-0798, Fax: +82-52-230-0791, e-mail: ekjung@mail.uc.ac.kr

Received 23 May 2007       Accepted 20 June 2007

Copyright © 2007 Journal of Bacteriology and Virology

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

One of the traditional Korean medicine, Drynaria fortunei (D. fortunei) is one of candidates known to be effective for the treatment of inflammation, hyperlipemia, arteriosclerosis, rheumatism, and gynecological diseases such as osteoporosis and bone resorption. The present study investigated the antimicrobial activity of methanol (MeOH) extract and n-butanol (n-BuOH), chloroform (CHCl3), and ethyl acetate (EtOAc) fractions of D. fortunei against oral bacteria. The n-BuOH and CHCl3 fractions (MICs, 0.0078 to 0.3125 mg/ml; MBCs, 0.019 to 0.625 mg/ml) were demonstrated as strong antibacterial activity than the MeOH extract and EtOAc fraction. The combination effects of n-BuOH fraction with ampicillin or gentamicin were synergistic against some oral bacteria. We suggest that D. fortunei could be employed as a natural antibacterial agent in oral care products.

Keywords: Drynaria fortunei, Antibacterial activity, Minimum inhibitory concentrations/minimum bactericidal concentrations

References

1). Cha JD, Jeong MR, Jeong SL, Moon SE, Kim JY, Kil BS, Song YH. Chemical composition and anti-microbial activity of the essential oils of Artemisia scoparia and A. capillaris. Planta Med. 2:186–190. 2005.
2). Climo MW, Patron RL, Archer GL. Combinations of vancomycin and beta-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin. Antimicrob Agents Chemother. 43:1747–1753. 1999.
3). Hada S, Kakiuchi N, Hattori M, Namba T. Identification of antibacterial principles against Streptococcus mutans and inhibitory principles against glucosyltransferase from the seed of Areca catechu L. Phytother Research. 3:140–144. 1989.
4). Ha TY, Won KK, Whang HS, Park JW. Antimicrobial activity and combination effect of drugs to Vibrio vulnificus. J Bacteriol Virol. 26:519–530. 1991.
5). Huang HF, You JS. The use of Chinese herbal medicine on experimental fracture healing. Am J Chin Med. 25:351–356. 1997.
crossref
6). Jeong JC, Kang SK, Yoon CH, Jeong CW, Kim HM, Lee YC, Chang YC, Kim CH. Inhibition of Drynariae Rhizoma extracts on bone resorption mediated by processing of cathepsin K in cultured mouse osteoclasts. Int Immunopharmacol. 3:1685–1697. 2003.
7). Liu B. Effects of Lycium barbarum L and Drynaria fortunei J Smith on in vitro attachment and growth of human gingival fibroblasts on root surfaces. Zhonghua Kou Qiang Yi Xue Za Zhi. 27:159–161. 1992.
8). Liu HC, Chen RM, Jian WC, Lin YL. Cytotoxic and antioxidant effects of the water extract of the traditional Chinese herb gusuibu (Drynaria fortunei) on rat osteoblasts. J Formos Med Assoc. 100:383–388. 2001.
9). Long M, Smouha EE, Qiu D, Li F, Johnson F, Luft B. Flavanoid of Drynaria fortunei protects against gentamicin ototoxicity. Phytother Res. 18:609–614. 2004.
10). Long M, Qiu D, Li F, Johnson F, Luft B. Flavonoid of Drynaria fortunei protects against acute renal failure. Phytother Res. 19:422–427. 2005.
11). Menezes SM, Codeiro LN, Viana GS. Punica granatum (pomegranate) extract is active against dental plaque. J Herb Pharmacother. 6:79–92. 2006.
12). Moulari B, Lboutounne H, Chaumont JP, Guillaume Y, Miller J, Pellequer Y. Potentiation of the bactericidal activity of Harungana madagascariensis Lam. ex Poir. (Hypericaceae) leaf extract against oral bacteria using poly (D, L-lactide-co-glycolide) nanoparticles: in vitro study. Acta Odontol Scand. 64:153–158. 2006.
13). Nakahara K, Kawabata S, Ono H, Ogura K, Tanaka T, Ooshima T, Hamada S. Inhibitory effect of oolong tea polyphenols on glucosyltransferases of mutans streptococci. Appl Environ Microbiol. 59:968–973. 1993.
14). Ooshima T, Osaka Y, Sasaki H, Osawa K, Yasuda H, Matsumura M, Sobue S, Matsumoto M. Caries inhibitory activity of cacao bean husk extract in in-vitro and animal experiments. Arch Oral Biol. 45:639–645. 2000.
crossref
15). Roldan S, Winkel EG, Herrera D, Sanz M, Van Winkelhoff AJ. The effects of a new mouthrinse containing chlorhexidine, cetylpyridinium chloride and zinc lactate on the microflora of oral halitosis patients: a dual-centre, double-blind placebo-controlled study. J Clin Periodontol. 30:427–434. 2003.
16). Sterer N. Antimicrobial effect of mastic gum methanolic extract against Porphyromonas gingivalis. J Med Food. 9:290–292. 2006.
17). Sun JS, Lin CY, Dong GC, Sheu SY, Lin FH, Chen LT, Wang YJ. The effect of Gu-Sui-Bu (Drynaria fortunei J Sm) on bone cell activities. Biomaterials. 23:3377–3385. 2002.
18). Wang Z. Experimental study of Rhizoma drynariae (Gusuibu) in the treatment of streptomycin ototoxicity. Zhonghua Er Bi Yan Hou Ke Za Zhi. 24:79–81. 1989.
19). Wolinsky LE, Sote EO. Inhibiting effect of aqueous extracts of eight Nigerian chewing sticks on bacterial properties favouring plaque formation. Caries Res. 17:253–257. 1983.
20). Wong RW, Rabie AB. Systemic effect of crude extract from rhizome of Drynaria fortunei on bone formation in mice. Phytother Res. 20:313–315. 2006.

Figure 1.
Time-kill curves of MCs of n-BuOH fraction alone and its combination with MICs of ampicillin or gentamicin against. S. mutans, S. sanguinis, S. sobrinus, S. anginosus, S. criceti, and S. ratti. Bacteria were incubated with n-BuOH fraction along (), n-BuOH fraction with ampicillin (❍), and n-BuOH fraction with gentamicin (▾) over time. Data points are the mean values ± S.E.M. of four experiments. CFU, colony-forming units.
jbv-37-61f1.tif
Figure 2.
Time-kill curves of MICs of n-BuOH fraction alone and its combination with MICs of ampicillin or gentamicin against S. gordonii, A. actinomycetemcomitans, F. nucleatum, P. intermedia, and P. gingivalis. Bacteria were incubated with n-BuOH fraction along (), n-BuOH fraction with ampicillin (❍), and n-BuOH fraction with gentamicin (▾) over time. Data points are the mean values ± S.E.M. of four experiments. CFU, colony-forming units.
jbv-37-61f2.tif
Table 1.
Minimum inhibitory concentrations and minimum bactericidal concentrations (mg/ml) of the extract and several fractions of Drynaria fortunei for some oral bacteria
Strains Drynaria fortunei extract and fractions MICs/MBCs (mg/ml)
MeOH n-BuOH CHCl3 EtOAc Ampicillin Gentamicin
S. mutans ATCC 25175 5/5 0.3125/0.625 0.078/0.156 5/10 4/4×10–3 8/8×10–3
S. sanguinis ATCC 10556 2.5/5 0.3125/0.625 0.078/0.156 5/10 32/32×10–3 8/16×10–3
S. sobrinus ATCC 27607 2.5/2.5 0.019/0.039 0.078/0.156 2.5/2.5 2/2×10–3 4/8×10–3
S. ratti KCTC 3294 5/5 0.0078/0.019 0.156/0.3125 5/10 4/4×10–3 4/8×10–3
S. criceti 1KCTC 3292 2.5/2.5 5/10 0.156/0.3125 2.5/2.5 4/4×10–3 8/8×10–3
S. anginosus ATCC 31412 2.5/2.5 0.0078/0.019 0.019/0.039 2.5/5 4/4×10–3 16/16×10–3
S. gordonii ATCC 10558 1.25/2.5 0.156/0.3125 0.039/0.156 0.3125/0.3125 1/2×10–3 2/4×10–3
A. actinomycetemcomitans ATCC 43717 5/5 1.25/2.5 2.5/5 5/10 64/64×10–3 2/2×10–3
F. nucleatum ATCC 51190 2.5/5 1.25/2.5 1.25/1.25 2.5/2.5 0.25/0.25×10–3 16/32×10–3
P. intermedia ATCC 49046 0.019/0.039 0.019/0.019 0.019/0.039 0.039/0.039 32/32×10–3 0.5/1×10–3
P. gingivalis ATCC 33277 0.625/0.625 0.019/0.039 0.019/0.019 1.25/1.25 0.5/1×10–3 256/512×10–3

1 Korean Collection for Type Cultures

Table 2.
The MeOH extract and n-BuOH fraction of Drynaria fortunei with or without ampicillin against some oral bacteria
Strains MIC1 MIC (mg/ml) FIC2 (mg/ml) FICI3 Outcome
MeOH n-BuOH MeOH n-BuOH MeOH n-BuOH MeOH n-BuOH
S. mutans Alone 1.25 0.039 0.25 0.125 0.5 0.375 Synergistic Synergistic
ATCC 25175 Ampicillin 1×10–3 0.5×10–3 0.25 0.25        
S. sanguinis Alone 0.625 0.039 0.25 0.25 0.375 0.5 Synergistic Synergistic
ATCC 10556 Ampicillin 4×10–3 2×10–3 0.125 0.25        
S. sobrinus Alone 1.25 0.0045 0.5 0.25 0.623 0.31 Additive Synergistic
ATCC 27607 Ampicillin 0.25×10–3 0.125×10–3 0.123 0.063        
S. ratti Alone 1.25 0.019 0.25 0.5 0.75 1 Additive Additive
KCTC 3294 Ampicillin 2×10–3 1×10–3 0.5 0.5        
S. criceti Alone 0.625 1.25 0.25 0.25 0.75 0.75 Additive Additive
KCTC 3292 Ampicillin 2×10–3 1×10–3 0.5 0.5        
S. anginosus Alone 0.3125 0.019 0.25 0.25 0.75 0.75 Additive Additive
ATCC 31412 Ampicillin 2×10–3 2×10–3 0.5 0.5        
S. gordonii Alone 0.3125 0.019 0.25 0.125 0.5 0.375 Synergistic Synergistic
ATCC 10558 Ampicillin 0.25×10–3 0.125×10–3 0.25 0.25        
A. actinomycetemcomitans Alone 1.25 0.156 0.25 0.063 0.375 0.31 Synergistic Synergistic
ATCC 43717 Ampicillin 8×10–3 4×10–3 0.125 0.25        
F. nucleatum Alone 0.3125 0.078 0.125 0.063 0.625 0.5 Additive Synergistic
ATCC 51190 Ampicillin 0.125×10–3 0.063×10–3 0.5 0.25        
P. intermedia Alone 0.0045 0.0045 0.25 0.25 0.5 0.5 Synergistic Synergistic
ATCC 49049 Ampicillin 8×10–3 4×10–3 0.25 0.25        
P. gingivalis Alone 0.039 0.0025 0.063 0.25 0.313 0.31 Synergistic Synergistic
ATCC 33277 Ampicillin 0.125×10–3 0.063×10–3 0.25 0.063        

1 The MICs of MeOH extract and n-BuOH fraction of Drynaria fortunei with or without ampicillin against oral bacteria are indicated.

2 Fractional inhibitory concentration (FIC) was calculated by the combined MICs of the MeOH extract and n-BuOH fraction with or without ampicillin.

3 Fractional inhibitory concentration index (FICI) = (MIC of combination X + Y) / (MIC of drug X alone) + (MIC of combination X + Y) / (MIC of drug Y alone).

Table 3.
The MeOH extract and n-BuOH fraction of Drynaria fortunei with or without gentamicin against some oral bacteria
Strains MIC1 MIC (mg/ml) FIC2 (mg/ml) FICI3 Outcome
MeOH n-BuOH MeOH n-BuOH MeOH n-BuOH MeOH n-BuOH
S. mutans Alone 1.25 0.019 0.25 0.125 0.75 0.5 Additive Synergistic
ATCC 25175 Ampicillin 4×10–3 2×10–3 0.5 0.25        
S. sanguinis Alone 0.625 0.039 0.25 0.25 0.31 0.31 Synergistic Synergistic
ATCC 10556 Ampicillin 4×10–3 2×10–3 0.5 0.25        
S. sobrinus Alone 0.3125 0.0025 0.5 0.25 1 1 Additive Additive
ATCC 27607 Ampicillin 0.5×10–3 0.5×10–3 0.123 0.063        
S. ratti Alone 0.625 0.009 0.25 0.5 0.75 0.75 Additive Additive
KCTC 3294 Ampicillin 1×10–3 1×10–3 0.5 0.5        
S. criceti Alone 0.625 0.625 0.25 0.25 0.75 0.75 Additive Additive
KCTC 3292 Ampicillin 0.5×10–3 0.25×10–3 0.5 0.5        
S. anginosus Alone 0.3125 0.019 0.25 0.25 0.375 0.375 Synergistic Synergistic
ATCC 31412 Ampicillin 1×10–3 0.5×10–3 0.5 0.5        
S. gordonii Alone 0.156 0.019 0.25 0.125 0.31 0.31 Synergistic Synergistic
ATCC 10558 Ampicillin 1×10–3 1×10–3 0.25 0.25        
A. actinomycetemcomitans Alone 0.625 0.078 0.25 0.063 0.5 0.5 Synergistic Synergistic
ATCC 43717 Ampicillin 0.5×10–3 0.5×10–3 0.125 0.25        
F. nucleatum Alone 0.625 0.039 0.125 0.063 0.5 0.5 Synergistic Synergistic
ATCC 51190 Ampicillin 4×10–3 2×10–3 0.5 0.25        
P. intermedia Alone 0.009 0.0025 0.25 0.25 0.31 0.31 Synergistic Synergistic
ATCC 49049 Ampicillin 0.25×10–3 0.125×10–3 0.25 0.25        
P. gingivalis Alone 0.0045 0.0025 0.063 0.25 0.75 0.5 Additive Synergistic
ATCC 33277 Ampicillin 32×10–3 8×10–3 0.25 0.063        

1 The MICs of MeOH extract and n-BuOH fraction of Drynaria fortunei with or without gentamicin against oral bacteria are indicated.

2 Fractional inhibitory concentration (FIC) was calculated by the combined MICs of the MeOH extract and n-BuOH fraction with or without gentamicin.

3 Fractional inhibitory concentration index (FICI) = (MIC of combination X + Y) / (MIC of drug X alone) + (MIC of combination X + Y) / (MIC of drug Y alone).

TOOLS
Similar articles